| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |